Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Medtronic plc (NYSE:MDT ... Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Pharmac – Te Pātaka Whaioranga has decided to fund continuous glucose monitors (CGMs), insulin pumps, and insulin pump consumables for people with type 1 diabetes from 1 October 2024.

Medtronic (NYSE: MDT) is a leading manufacturer of medical devices globally. Its products include pacemakers, insulin pumps, insulin pens, and continuous glucose monitoring devices, to name ...

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G ... There will continue to be a dire need for products that help simplify the lives of these patients.

Bridgewater Associates is loading up on shares of ExxonMobil, Medtronic, and Microsoft. Here's what you need to know.

The clinical studies required by regulators prior to marketing are small and over-reliant on bench testing in relation to "predicate" products. Once a pump is available on the market, insufficient ...

The Medtronic MiniMed pump will serve as one of Tidepool Loop’s accessories ... to develop and commercialize integrated ...

For instance, in addition to other Abbott devices, products made by Medtronic, Abiomed ... its Impella 2.5 intravascular micro axial blood pump, which supports the heart. In patients with a ...